Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02115048
Title Clinical Study for the Treatment of Breast Cancer the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Translational Research in Oncology
Indications
Therapies
Age Groups: adult
Covered Countries USA | ROU | ESP


No variant requirements are available.